Insulin-like growth factor-I and cancer mortality in older men
- PMID: 20080855
- PMCID: PMC2841529
- DOI: 10.1210/jc.2009-1378
Insulin-like growth factor-I and cancer mortality in older men
Abstract
Context: Although numerous studies have explored the relation of IGF-I with cancer incidence, few have investigated the association between IGF-I and cancer mortality.
Objective: This study examined the association of serum IGF-I levels with cancer mortality in older community-dwelling men.
Design, setting, and participants: We conducted a prospective, population-based study of 633 men aged 50 yr and older (mean = 73) who attended a 1988-1991 research clinic visit when blood was obtained for measurement of IGF-I. Participants were followed for vital status through July 2006.
Main outcome measure: All-cancer mortality was assessed.
Results: Median IGF-I was 96 ng/ml. During the 18-yr follow-up, 368 deaths occurred; 74 (20%) were due to cancer. Cox regression analyses showed a significant quadratic association between IGF-I and all-cancer mortality (P = 0.039). Higher levels of IGF-I were associated with progressively higher risk of cancer death after adjusting for age, IGF-binding protein-1, adiposity, exercise, current smoking, and previous cancer. The adjusted risk of cancer death was statistically significant for IGF-I levels above 120 ng/ml, with magnitudes of effect ranging from 1.61 [95% confidence interval (CI) = 1.28-2.02] to 2.61 (95% CI = 1.46-4.64). For the 46% of men with IGF-I above 100 ng/ml, the risk of fatal cancer was 1.82 (95% CI = 1.11-2.96) compared to the risk with lower levels.
Conclusions: Higher serum IGF-I in older men is associated with increased risk of cancer death, independent of age, adiposity, lifestyle, and cancer history. These results suggest caution in the use of IGF-I-enhancing therapies to slow the adverse effects of aging.
Figures
References
-
- American Cancer Society 2007 Cancer Facts and Figures. Atlanta: American Cancer Society
-
- Moschos SJ, Mantzoros CS 2002 The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63:317–332 - PubMed
-
- Pollak M 2000 Insulin-like growth factor physiology and cancer risk. Eur J Cancer 36:1224–1228 - PubMed
-
- Djavan B, Waldert M, Seitz C, Marberger M 2001 Insulin-like growth factors and prostate cancer. World J Urol 19:225–233 - PubMed
-
- Dunn SE, Kari FW, French J, Leininger JR, Travlos G, Wilson R, Barrett JC 1997 Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57:4667–4672 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
